siliconindia | | DECEMBER 20249Government of Karnataka shared her thoughts on biotechnology."I'm very excited about the bioethics policy, because bio-manufacturing is going to provide answers to many challenges that we face today. Whether it is energy, food, feed or biomaterials, we have a lot to gain from bio-manufacturing as today, between synthetic biology and cell-based fermentation through microbial or mammalian cells, we are able to look at disease, nutrition, and sustainability in a very different way. Preeminently, the bioethics policy is actually focused on these three Es - Environment, Economy, and Employment. I think Karnataka needs to focus on using technology-driven approaches to biology and bio-manufacturing, and I believe that this is the future. This is where we have the strengths to combine artificial intelligence and the power of biology", she adds.What's Fueling Predictive biotechnology Growth in 2024?Unsurprisingly, AI is converting the biotech industry by updating drug discovery, raising clinical trials, and creating precision medicine possible. The application of AI in analyzing enormous data sets and predicting biological results has opened new possibilities in drug discovery, precision healthcare, and even early disease detection. As the technology matures, its integration into biotech processes continues to yield concrete advancements, driving significant progress in predictive modeling for clinical and preclinical applications.The biotechnology market is expected to experience a rapid growth rate across the globe, according to Prophecy Market Insights, due to technology advancements and the rising demand for quality healthcare from the elderly population. Predictive biotechnology is one of the most important technologies reshaping patient care, including the wide adoption of telemedicine, personalized medicine, and AI-driven solutions. These technologies will offer better predictions of patient outcomes while optimizing treatment plans in the clinical setting, minimizing trial-and-error.The new era in biotechnology is defined by the integration of biology, data analytics, and AI. Connected lab instruments, cloud-based scientific applications, R&D data platforms, and AI tools are all becoming core to predictive biotech's activities. This technology integrates biological research with data-driven insights, making companies predict biological behaviors more accurately while improving both scale and efficiency. The tech-forward strategy is fast becoming a competitive advantage for predictive biotechnology companies in an increasingly data-driven industry.In conclusion, biotechnology, specifically predictive biotechnology, remains at the top of its challenges, providing added accuracy for AI, making it affordable, and making solutions to ethical dilemmas. Despite such barriers, resilience within the industry continues to drive progress, coupled with advanced technologies and sustainable practices that reposition healthcare and sustainability in unprecedented ways. Biotechnology, taking a determined stride towards delivering transformational solutions, envisions to redraw its blueprint in better service to humanity and the planet. 99The bioethics policy is actually focused on three Es, namely Environment, Economy, and Employment
< Page 8 | Page 10 >